MAIA Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 582,507 | $1.15 M | 2.85% | 2.44% |
HALTER FERGUSON FINANCIAL INC. | 02/11/2025 | 240,818 | $476,821 | -36.07% | 1.01% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 197,524 | $391,241 | 2.58% | 0.83% |
BLACKROCK, INC. | 02/07/2025 | 84,785 | $167,875 | 6.34% | 0.35% |
CENTRIC WEALTH MANAGEMENT | 02/12/2025 | 68,219 | $135,074 | 0.00% | 0.29% |
STATE STREET CORP | 02/14/2025 | 53,250 | $105,435 | 54.80% | 0.22% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 45,700 | $90,486 | 0.00% | 0.19% |
JANE STREET GROUP, LLC | 02/14/2025 | 39,057 | $77,333 | 100.00% | 0.16% |
NORTHERN TRUST CORP | 02/14/2025 | 32,071 | $63,501 | 0.00% | 0.13% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 14,800 | $29,304 | 0.00% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 11,649 | $23,065 | 100.00% | 0.05% |
MORGAN STANLEY | 02/14/2025 | 5,095 | $10,088 | 0.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,285 | $6,504 | 124.08% | 0.01% |
ROYAL BANK OF CANADA | 02/14/2025 | 3,000 | $6,000 | 100.00% | 0.01% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 675 | $1,337 | 100.00% | 0.00% |
02/27/2025 | 500 | $990 | 100.00% | 0.00% | |
TUCKER ASSET MANAGEMENT LLC | 02/12/2025 | 341 | $675 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 164 | $325 | 5.13% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 45 | $89 | -4.26% | 0.00% |
UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SUNBELT SECURITIES, INC. | 02/18/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NAVITER WEALTH, LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
MAIA Biotechnology, Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of MAIA Biotechnology, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 582,507
Halter Ferguson Financial Inc.: 240,818
GEODE CAPITAL MANAGEMENT, LLC: 197,524
BlackRock, Inc.: 84,785
Centric Wealth Management: 68,219
STATE STREET CORP: 53,250
5.79% of MAIA Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.46 M shares in the last 24 months. This purchase volume represents approximately $2.16 M in transactions.